AVGR Quote, Trading Chart, Avinger Inc.
home / stock / avgr / avgr quote
$1.3452 Last:
-3.22% Change Percent:
$1.437 Open:
$1.3452 Previous Close:
$1.448 High:
$1.11 Low:
6,770,175 Volume:
03/05/2021 02:30:38 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-05 | 1.437 | 1.3452 | 1.448 | 1.11 | 6,770,175 |
| 2021-03-04 | 1.613 | 1.39 | 1.63 | 1.33 | 7,892,297 |
| 2021-03-03 | 1.7114 | 1.63 | 1.73 | 1.5827 | 4,432,963 |
| 2021-03-02 | 1.7422 | 1.71 | 1.82 | 1.68 | 6,222,960 |
| 2021-03-01 | 1.68 | 1.68 | 1.715 | 1.63 | 3,073,023 |
| 2021-02-26 | 1.67 | 1.6 | 1.7 | 1.55 | 4,628,219 |
| 2021-02-25 | 1.75 | 1.65 | 1.765 | 1.61 | 6,231,471 |
| 2021-02-24 | 1.68 | 1.68 | 1.86 | 1.66 | 6,663,957 |
| 2021-02-23 | 1.71 | 1.65 | 1.76 | 1.52 | 8,608,710 |
| 2021-02-22 | 1.88 | 1.83 | 1.95 | 1.8 | 6,193,587 |
| 2021-02-19 | 2.07 | 1.91 | 2.1116 | 1.88 | 15,927,081 |
| 2021-02-18 | 2.38 | 2.1 | 2.67 | 2.07 | 122,449,730 |
| 2021-02-17 | 1.81 | 1.69 | 1.81 | 1.64 | 6,980,443 |
| 2021-02-16 | 1.9 | 1.83 | 1.9094 | 1.7 | 6,726,341 |
| 2021-02-15 | 1.84 | 1.83 | 1.92 | 1.78 | 5,195,841 |
| 2021-02-12 | 1.84 | 1.83 | 1.92 | 1.78 | 5,135,030 |
| 2021-02-11 | 2 | 1.87 | 2 | 1.75 | 12,142,311 |
| 2021-02-10 | 2.14 | 1.99 | 2.17 | 1.86 | 13,765,176 |
| 2021-02-09 | 2.04 | 2.01 | 2.2 | 1.9 | 18,768,637 |
| 2021-02-08 | 1.88 | 1.97 | 2.05 | 1.82 | 18,800,816 |
News, Short Squeeze, Breakout and More Instantly...
-
REDWOOD CITY, CA / ACCESSWIRE / March 2, 2021 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that it will rel...
-
Biotech Penny Stocks To Watch Right Now If one grouping of penny stocks that’ve gained attention in the markets, it has been biotech stocks. These companies focus on novel treatments and develop groundbreaking platforms addressing unmet medical needs worldwide. Obviously, cor...
-
NEW YORK, NY / ACCESSWIRE / February 3, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $14.4 Million Bought Deal Offering for Avinger, Inc. (NASDAQ:AVGR) About Avinger, Inc . Avinger is a commercial-stage medical device company that designs and develops the first and only ...